ISDA

Entry Detail

PDB ID:

2BTS

Keywords:

TRANSFERASE

Title:

STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032

Biological Source:

Source Organism:

HOMO SAPIENS

Host Organism:

TRICHOPLUSIA NI

PDB Version:

Deposition Date:

2005-06-06

Release Date:

2005-11-09

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.99 Å

R-Value Free:

0.26

R-Value Work:

0.21

R-Value Observed:

0.21

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:CELL DIVISION PROTEIN KINASE 2
Chain IDs:A
Chain Length:298
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P24941 Pfam ID:PF00069 EC:2.7.11.22

Ligand Molecules

U32

Primary Citation

Structure-Based Drug Design to the Discovery of New 2-Aminothiazole Cdk2 Inhibitors.

Vulpetti, A, Casale, E, Roletto, F, Amici, R, Villa, M, Pevarello, P.Show

J.Mol.Graph.Model. 24 341 ? (2006)

PMID: 16260160 DOI: 10.1016/J.JMGM.2005.09.012

Abstact

N-(5-Bromo-1,3-thiazol-2-yl)butanamide (compound 1) was found active (IC50=808 nM) in a high throughput screening (HTS) for CDK2 inhibitors. By exploiting crystal structures of several complexes between CDK2 and inhibitors and applying structure-based drug design (SBDD), we rapidly discovered a very potent and selective CDK2 inhibitor 4-[(5-isopropyl-1,3-thiazol-2-yl)amino] benzenesulfonamide (compound 4, IC50=20 nM). The syntheses, structure-based analog design, kinases inhibition data and X-ray crystallographic structures of CDK2/inhibitor complexes are reported.

Legend

Protein

Chemical

Disease

Primary Citation of related structures